Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer

<p>Supplementary Figure S6. Distribution of HER2 gene ratio in relation to PIK3CA mutation status and HER2-enriched subtype.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Jamunarani Veeraraghavan (16461809) (author)
Diğer Yazarlar:	Carolina Gutierrez (14958125) (author), Carmine De Angelis (16461812) (author), Robert Davis (16461815) (author), Tao Wang (14952136) (author), Tomas Pascual (16461818) (author), Pier Selenica (15052857) (author), Katherine Sanchez (16461821) (author), Hiroaki Nitta (16461824) (author), Monesh Kapadia (16461827) (author), Anne C. Pavlick (16461830) (author), Patricia Galvan (16461833) (author), Brent Rexer (16461836) (author), Andres Forero-Torres (15053759) (author), Rita Nanda (15034401) (author), Anna M. Storniolo (16461839) (author), Ian E. Krop (15029231) (author), Matthew P. Goetz (8863130) (author), Julie R. Nangia (15123189) (author), Antonio C. Wolff (15017274) (author), Britta Weigelt (15051465) (author), Jorge S. Reis-Filho (15052878) (author), Susan G. Hilsenbeck (14952139) (author), Aleix Prat (14950504) (author), C. Kent Osborne (15055636) (author), Rachel Schiff (14958948) (author), Mothaffar F. Rimawi (15055651) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Detection and Diagnosis Biomarkers Prognostic biomarkers Breast Cancer
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller